Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

A Genome-Wide Functional Genomics Approach Identifies Susceptibility Pathways to Fungal Bloodstream Infection in Humans.

Jaeger M, Matzaraki V, Aguirre-Gamboa R, Gresnigt MS, Chu X, Johnson MD, Oosting M, Smeekens SP, Withoff S, Jonkers I, Perfect JR, van de Veerdonk FL, Kullberg BJ, Joosten LAB, Li Y, Wijmenga C, Netea MG, Kumar V.

J Infect Dis. 2019 Jul 31;220(5):862-872. doi: 10.1093/infdis/jiz206.

PMID:
31241743
2.

Exome sequencing in routine diagnostics: a generic test for 254 patients with primary immunodeficiencies.

Arts P, Simons A, AlZahrani MS, Yilmaz E, AlIdrissi E, van Aerde KJ, Alenezi N, AlGhamdi HA, AlJubab HA, Al-Hussaini AA, AlManjomi F, Alsaad AB, Alsaleem B, Andijani AA, Asery A, Ballourah W, Bleeker-Rovers CP, van Deuren M, van der Flier M, Gerkes EH, Gilissen C, Habazi MK, Hehir-Kwa JY, Henriet SS, Hoppenreijs EP, Hortillosa S, Kerkhofs CH, Keski-Filppula R, Lelieveld SH, Lone K, MacKenzie MA, Mensenkamp AR, Moilanen J, Nelen M, Ten Oever J, Potjewijd J, van Paassen P, Schuurs-Hoeijmakers JHM, Simon A, Stokowy T, van de Vorst M, Vreeburg M, Wagner A, van Well GTJ, Zafeiropoulou D, Zonneveld-Huijssoon E, Veltman JA, van Zelst-Stams WAG, Faqeih EA, van de Veerdonk FL, Netea MG, Hoischen A.

Genome Med. 2019 Jun 17;11(1):38. doi: 10.1186/s13073-019-0649-3.

3.

A systems genomics approach identifies SIGLEC15 as a susceptibility factor in recurrent vulvovaginal candidiasis.

Jaeger M, Pinelli M, Borghi M, Constantini C, Dindo M, van Emst L, Puccetti M, Pariano M, Ricaño-Ponce I, Büll C, Gresnigt MS, Wang X, Gutierrez Achury J, Jacobs CWM, Xu N, Oosting M, Arts P, Joosten LAB, van de Veerdonk FL, Veltman JA, Ten Oever J, Kullberg BJ, Feng M, Adema GJ, Wijmenga C, Kumar V, Sobel J, Gilissen C, Romani L, Netea MG.

Sci Transl Med. 2019 Jun 12;11(496). pii: eaar3558. doi: 10.1126/scitranslmed.aar3558.

PMID:
31189718
4.

Detection of Invasive Aspergillosis in Critically Ill Patients with Influenza: The Role of Plasma Galactomannan.

van de Groep K, Verboom DM, van de Veerdonk FL, Haas PA, van der Poll T, Schultz MJ, Bonten MJM, Cremer OL.

Am J Respir Crit Care Med. 2019 Sep 1;200(5):636-638. doi: 10.1164/rccm.201903-0587LE. No abstract available.

PMID:
31042411
5.

Tetraspanin CD82 Organizes Dectin-1 into Signaling Domains to Mediate Cellular Responses to Candida albicans.

Tam JM, Reedy JL, Lukason DP, Kuna SG, Acharya M, Khan NS, Negoro PE, Xu S, Ward RA, Feldman MB, Dutko RA, Jeffery JB, Sokolovska A, Wivagg CN, Lassen KG, Le Naour F, Matzaraki V, Garner EC, Xavier RJ, Kumar V, van de Veerdonk FL, Netea MG, Miranti CK, Mansour MK, Vyas JM.

J Immunol. 2019 Jun 1;202(11):3256-3266. doi: 10.4049/jimmunol.1801384. Epub 2019 Apr 22.

PMID:
31010852
6.

STAT1 gain-of-function compromises skin host defense in the context of IFN-γ signaling.

Niehues H, Rösler B, van der Krieken DA, van Vlijmen-Willems IMJJ, Rodijk-Olthuis D, Peppelman M, Schalkwijk J, van den Bogaard EHJ, Zeeuwen PLJM, van de Veerdonk FL.

J Allergy Clin Immunol. 2019 Apr;143(4):1626-1629.e5. doi: 10.1016/j.jaci.2018.11.033. Epub 2018 Dec 18. No abstract available.

PMID:
30576757
7.

Influenza virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality.

Beumer MC, Koch RM, van Beuningen D, OudeLashof AM, van de Veerdonk FL, Kolwijck E, van der Hoeven JG, Bergmans DC, Hoedemaekers CWE.

J Crit Care. 2019 Apr;50:59-65. doi: 10.1016/j.jcrc.2018.11.013. Epub 2018 Nov 15.

PMID:
30481669
8.

Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.

Schauwvlieghe AFAD, Rijnders BJA, Philips N, Verwijs R, Vanderbeke L, Van Tienen C, Lagrou K, Verweij PE, Van de Veerdonk FL, Gommers D, Spronk P, Bergmans DCJJ, Hoedemaekers A, Andrinopoulou ER, van den Berg CHSB, Juffermans NP, Hodiamont CJ, Vonk AG, Depuydt P, Boelens J, Wauters J; Dutch-Belgian Mycosis study group.

Lancet Respir Med. 2018 Oct;6(10):782-792. doi: 10.1016/S2213-2600(18)30274-1. Epub 2018 Jul 31.

PMID:
30076119
9.

HDAC inhibitors modulate innate immune responses to micro-organisms relevant to chronic mucocutaneous candidiasis.

Rösler B, Wang X, Keating ST, Joosten LAB, Netea MG, van de Veerdonk FL.

Clin Exp Immunol. 2018 Nov;194(2):205-219. doi: 10.1111/cei.13192. Epub 2018 Oct 1.

10.

Host Genetic Signatures of Susceptibility to Fungal Disease.

Campos CF, van de Veerdonk FL, Gonçalves SM, Cunha C, Netea MG, Carvalho A.

Curr Top Microbiol Immunol. 2019;422:237-263. doi: 10.1007/82_2018_113. Review.

PMID:
30043341
11.

Microbiological and immunological characteristics of a lethal pulmonary Aspergillus niger infection in a non-neutropenic patient.

Workum JD, de Jong SW, Gresnigt MS, Becker KL, Pickkers P, van de Veerdonk FL, Heijdra YF, Kolwijck E.

Med Mycol Case Rep. 2018 Mar 7;21:4-7. doi: 10.1016/j.mmcr.2018.03.002. eCollection 2018 Sep.

12.

Genetic deficiency of NOD2 confers resistance to invasive aspergillosis.

Gresnigt MS, Cunha C, Jaeger M, Gonçalves SM, Malireddi RKS, Ammerdorffer A, Lubbers R, Oosting M, Rasid O, Jouvion G, Fitting C, Jong DJ, Lacerda JF, Campos A Jr, Melchers WJG, Lagrou K, Maertens J, Kanneganti TD, Carvalho A, Ibrahim-Granet O, van de Veerdonk FL.

Nat Commun. 2018 Jul 6;9(1):2636. doi: 10.1038/s41467-018-04912-3.

13.

Antifungal immune responses: emerging host-pathogen interactions and translational implications.

Kumar V, van de Veerdonk FL, Netea MG.

Genome Med. 2018 May 25;10(1):39. doi: 10.1186/s13073-018-0553-2. Review.

14.

Moderate correlation between systemic IL-6 responses and CRP with trough concentrations of voriconazole.

Vreugdenhil B, van der Velden WJFM, Feuth T, Kox M, Pickkers P, van de Veerdonk FL, Blijlevens NMA, Brüggemann RJM.

Br J Clin Pharmacol. 2018 Sep;84(9):1980-1988. doi: 10.1111/bcp.13627. Epub 2018 Jun 19.

15.

Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects.

Schwab C, Gabrysch A, Olbrich P, Patiño V, Warnatz K, Wolff D, Hoshino A, Kobayashi M, Imai K, Takagi M, Dybedal I, Haddock JA, Sansom DM, Lucena JM, Seidl M, Schmitt-Graeff A, Reiser V, Emmerich F, Frede N, Bulashevska A, Salzer U, Schubert D, Hayakawa S, Okada S, Kanariou M, Kucuk ZY, Chapdelaine H, Petruzelkova L, Sumnik Z, Sediva A, Slatter M, Arkwright PD, Cant A, Lorenz HM, Giese T, Lougaris V, Plebani A, Price C, Sullivan KE, Moutschen M, Litzman J, Freiberger T, van de Veerdonk FL, Recher M, Albert MH, Hauck F, Seneviratne S, Pachlopnik Schmid J, Kolios A, Unglik G, Klemann C, Speckmann C, Ehl S, Leichtner A, Blumberg R, Franke A, Snapper S, Zeissig S, Cunningham-Rundles C, Giulino-Roth L, Elemento O, Dückers G, Niehues T, Fronkova E, Kanderová V, Platt CD, Chou J, Chatila TA, Geha R, McDermott E, Bunn S, Kurzai M, Schulz A, Alsina L, Casals F, Deyà-Martinez A, Hambleton S, Kanegane H, Taskén K, Neth O, Grimbacher B.

J Allergy Clin Immunol. 2018 Dec;142(6):1932-1946. doi: 10.1016/j.jaci.2018.02.055. Epub 2018 May 4.

PMID:
29729943
16.

Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases.

Rello J, van Engelen TSR, Alp E, Calandra T, Cattoir V, Kern WV, Netea MG, Nseir S, Opal SM, van de Veerdonk FL, Wilcox MH, Wiersinga WJ.

Clin Microbiol Infect. 2018 Dec;24(12):1264-1272. doi: 10.1016/j.cmi.2018.03.011. Epub 2018 Mar 24.

PMID:
29581049
17.

Recognition of DHN-melanin by a C-type lectin receptor is required for immunity to Aspergillus.

Stappers MHT, Clark AE, Aimanianda V, Bidula S, Reid DM, Asamaphan P, Hardison SE, Dambuza IM, Valsecchi I, Kerscher B, Plato A, Wallace CA, Yuecel R, Hebecker B, da Glória Teixeira Sousa M, Cunha C, Liu Y, Feizi T, Brakhage AA, Kwon-Chung KJ, Gow NAR, Zanda M, Piras M, Zanato C, Jaeger M, Netea MG, van de Veerdonk FL, Lacerda JF, Campos A, Carvalho A, Willment JA, Latgé JP, Brown GD.

Nature. 2018 Mar 15;555(7696):382-386. doi: 10.1038/nature25974. Epub 2018 Feb 28.

18.

The Multifaceted Role of T-Helper Responses in Host Defense against Aspergillus fumigatus.

Dewi IMW, van de Veerdonk FL, Gresnigt MS.

J Fungi (Basel). 2017 Oct 4;3(4). pii: E55. doi: 10.3390/jof3040055. Review.

19.

Metabolic Induction of Trained Immunity through the Mevalonate Pathway.

Bekkering S, Arts RJW, Novakovic B, Kourtzelis I, van der Heijden CDCC, Li Y, Popa CD, Ter Horst R, van Tuijl J, Netea-Maier RT, van de Veerdonk FL, Chavakis T, Joosten LAB, van der Meer JWM, Stunnenberg H, Riksen NP, Netea MG.

Cell. 2018 Jan 11;172(1-2):135-146.e9. doi: 10.1016/j.cell.2017.11.025.

20.

The Absence of NOD1 Enhances Killing of Aspergillus fumigatus Through Modulation of Dectin-1 Expression.

Gresnigt MS, Jaeger M, Subbarao Malireddi RK, Rasid O, Jouvion G, Fitting C, Melchers WJG, Kanneganti TD, Carvalho A, Ibrahim-Granet O, van de Veerdonk FL.

Front Immunol. 2017 Dec 13;8:1777. doi: 10.3389/fimmu.2017.01777. eCollection 2017.

21.

Development of Endotoxin Tolerance Does Not Influence the Response to a Challenge with the Mucosal Live-Attenuated Influenza Vaccine in Humans In Vivo.

Koch RM, Kox M, Thijs EJM, Rahamat-Langendoen JC, van de Veerdonk FL, Gerretsen J, Schloesser J, Diavatopoulos D, Rimmelzwaan GF, Netea MG, van der Hoeven JG, de Jonge MI, Pickkers P.

Front Immunol. 2017 Dec 11;8:1600. doi: 10.3389/fimmu.2017.01600. eCollection 2017.

22.

Are histones real pathogenic agents in sepsis?

van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG.

Nat Rev Immunol. 2018 Feb;18(2):148. doi: 10.1038/nri.2017.157. Epub 2017 Dec 27. No abstract available.

PMID:
29279614
23.

Differential Kinetics of Aspergillus nidulans and Aspergillus fumigatus Phagocytosis.

Gresnigt MS, Becker KL, Leenders F, Alonso MF, Wang X, Meis JF, Bain JM, Erwig LP, van de Veerdonk FL.

J Innate Immun. 2018;10(2):145-160. doi: 10.1159/000484562. Epub 2017 Dec 16.

24.

Biology of IL-38 and its role in disease.

van de Veerdonk FL, de Graaf DM, Joosten LA, Dinarello CA.

Immunol Rev. 2018 Jan;281(1):191-196. doi: 10.1111/imr.12612. Review.

PMID:
29247986
25.

Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease.

Zimmerman O, Rösler B, Zerbe CS, Rosen LB, Hsu AP, Uzel G, Freeman AF, Sampaio EP, Rosenzweig SD, Kuehn HS, Kim T, Brooks KM, Kumar P, Wang X, Netea MG, van de Veerdonk FL, Holland SM.

Open Forum Infect Dis. 2017 Sep 22;4(4):ofx202. doi: 10.1093/ofid/ofx202. eCollection 2017 Fall.

26.

Understanding the role of host immune responses in invasive candidiasis.

Desai JV, van de Veerdonk FL, Lionakis MS.

Intensive Care Med. 2018 Aug;44(8):1310-1314. doi: 10.1007/s00134-017-4988-5. Epub 2017 Nov 22. No abstract available.

PMID:
29167916
27.

Itraconazole or Amphotericin B for Talaromycosis.

Brüggemann RJ, van de Veerdonk FL, Verweij PE.

N Engl J Med. 2017 Oct 5;377(14):1402-1403. doi: 10.1056/NEJMc1709123. No abstract available.

PMID:
28976857
28.

The effects of signal transducer and activator of transcription three mutations on human platelets.

Aleva FE, van de Veerdonk FL, Li Y, Tunjungputri RN, Simons S, De Groot PG, Netea MM, Heijdra YF, de Mast Q, van der Ven AJAM.

Platelets. 2018 Sep;29(6):602-609. doi: 10.1080/09537104.2017.1349309. Epub 2017 Sep 29.

PMID:
28960117
29.

Rewiring monocyte glucose metabolism via C-type lectin signaling protects against disseminated candidiasis.

Domínguez-Andrés J, Arts RJW, Ter Horst R, Gresnigt MS, Smeekens SP, Ratter JM, Lachmandas E, Boutens L, van de Veerdonk FL, Joosten LAB, Notebaart RA, Ardavín C, Netea MG.

PLoS Pathog. 2017 Sep 18;13(9):e1006632. doi: 10.1371/journal.ppat.1006632. eCollection 2017 Sep.

30.

Aspergillus fumigatus morphology and dynamic host interactions.

van de Veerdonk FL, Gresnigt MS, Romani L, Netea MG, Latgé JP.

Nat Rev Microbiol. 2017 Nov;15(11):661-674. doi: 10.1038/nrmicro.2017.90. Epub 2017 Sep 18. Review.

PMID:
28919635
31.

Toll-like receptor 2 induced cytotoxic T-lymphocyte-associated protein 4 regulates Aspergillus-induced regulatory T-cells with pro-inflammatory characteristics.

Raijmakers RPH, Sprenkeler EGG, Aleva FE, Jacobs CWM, Kanneganti TD, Joosten LAB, van de Veerdonk FL, Gresnigt MS.

Sci Rep. 2017 Sep 13;7(1):11500. doi: 10.1038/s41598-017-11738-4.

32.

Immunotherapeutic approaches to treatment of fungal diseases.

Armstrong-James D, Brown GD, Netea MG, Zelante T, Gresnigt MS, van de Veerdonk FL, Levitz SM.

Lancet Infect Dis. 2017 Dec;17(12):e393-e402. doi: 10.1016/S1473-3099(17)30442-5. Epub 2017 Jul 31. Review.

33.

An integrative genomics approach identifies novel pathways that influence candidaemia susceptibility.

Matzaraki V, Gresnigt MS, Jaeger M, Ricaño-Ponce I, Johnson MD, Oosting M, Franke L, Withoff S, Perfect JR, Joosten LAB, Kullberg BJ, van de Veerdonk FL, Jonkers I, Li Y, Wijmenga C, Netea MG, Kumar V.

PLoS One. 2017 Jul 20;12(7):e0180824. doi: 10.1371/journal.pone.0180824. eCollection 2017.

34.

A guiding map for inflammation.

Netea MG, Balkwill F, Chonchol M, Cominelli F, Donath MY, Giamarellos-Bourboulis EJ, Golenbock D, Gresnigt MS, Heneka MT, Hoffman HM, Hotchkiss R, Joosten LAB, Kastner DL, Korte M, Latz E, Libby P, Mandrup-Poulsen T, Mantovani A, Mills KHG, Nowak KL, O'Neill LA, Pickkers P, van der Poll T, Ridker PM, Schalkwijk J, Schwartz DA, Siegmund B, Steer CJ, Tilg H, van der Meer JWM, van de Veerdonk FL, Dinarello CA.

Nat Immunol. 2017 Jul 19;18(8):826-831. doi: 10.1038/ni.3790.

35.

Uric acid priming in human monocytes is driven by the AKT-PRAS40 autophagy pathway.

Crişan TO, Cleophas MCP, Novakovic B, Erler K, van de Veerdonk FL, Stunnenberg HG, Netea MG, Dinarello CA, Joosten LAB.

Proc Natl Acad Sci U S A. 2017 May 23;114(21):5485-5490. doi: 10.1073/pnas.1620910114. Epub 2017 May 8.

36.

The immunopathology of sepsis and potential therapeutic targets.

van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG.

Nat Rev Immunol. 2017 Jul;17(7):407-420. doi: 10.1038/nri.2017.36. Epub 2017 Apr 24. Review.

PMID:
28436424
37.

Influenza-Associated Aspergillosis in Critically Ill Patients.

van de Veerdonk FL, Kolwijck E, Lestrade PP, Hodiamont CJ, Rijnders BJ, van Paassen J, Haas PJ, Oliveira Dos Santos C, Kampinga GA, Bergmans DC, van Dijk K, de Haan AF, van Dissel J, van der Hoeven HG, Verweij PE; Dutch Mycoses Study Group.

Am J Respir Crit Care Med. 2017 Aug 15;196(4):524-527. doi: 10.1164/rccm.201612-2540LE. Epub 2017 Apr 7. No abstract available.

PMID:
28387526
38.

Adjuvant interferon-gamma immunotherapy in a patient with progressive cerebral Nocardia abscesses.

Leentjens J, Gresnigt MS, van de Veerdonk FL, Kox M, Kullberg BJ, Pickkers P, Brouwer AE, Netea MG.

Int J Infect Dis. 2017 Jun;59:25-28. doi: 10.1016/j.ijid.2017.03.013. Epub 2017 Mar 22.

39.

Personalized medicine in influenza: a bridge too far or the near future?

van de Veerdonk FL, Gresnigt MS, Verweij PE, Netea MG.

Curr Opin Pulm Med. 2017 May;23(3):237-240. doi: 10.1097/MCP.0000000000000378. Review.

PMID:
28257314
40.

MST1R mutation as a genetic cause of Lady Windermere syndrome.

Becker KL, Arts P, Jaeger M, Plantinga TS, Gilissen C, van Laarhoven A, van Ingen J, Veltman JA, Joosten LA, Hoischen A, Netea MG, Iseman MD, Chan ED, van de Veerdonk FL.

Eur Respir J. 2017 Jan 18;49(1). pii: 1601478. doi: 10.1183/13993003.01478-2016. Print 2017 Jan. No abstract available.

41.

IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections.

Slaats J, Ten Oever J, van de Veerdonk FL, Netea MG.

PLoS Pathog. 2016 Dec 15;12(12):e1005973. doi: 10.1371/journal.ppat.1005973. eCollection 2016 Dec. Review.

42.

Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity.

Arts RJ, Novakovic B, Ter Horst R, Carvalho A, Bekkering S, Lachmandas E, Rodrigues F, Silvestre R, Cheng SC, Wang SY, Habibi E, Gonçalves LG, Mesquita I, Cunha C, van Laarhoven A, van de Veerdonk FL, Williams DL, van der Meer JW, Logie C, O'Neill LA, Dinarello CA, Riksen NP, van Crevel R, Clish C, Notebaart RA, Joosten LA, Stunnenberg HG, Xavier RJ, Netea MG.

Cell Metab. 2016 Dec 13;24(6):807-819. doi: 10.1016/j.cmet.2016.10.008. Epub 2016 Nov 17.

43.

New and recurrent STAT1 mutations in seven Chinese patients with chronic mucocutaneous candidiasis.

Wang X, Zhang R, Wu W, Wang A, Wan Z, van de Veerdonk FL, Li R.

Int J Dermatol. 2017 Feb;56(2):e30-e33. doi: 10.1111/ijd.13427. Epub 2016 Nov 3. No abstract available.

PMID:
27808400
44.

In-host adaptation and acquired triazole resistance in Aspergillus fumigatus: a dilemma for clinical management.

Verweij PE, Zhang J, Debets AJM, Meis JF, van de Veerdonk FL, Schoustra SE, Zwaan BJ, Melchers WJG.

Lancet Infect Dis. 2016 Nov;16(11):e251-e260. doi: 10.1016/S1473-3099(16)30138-4. Epub 2016 Sep 13. Review.

PMID:
27638360
45.

Iron refractory iron deficiency anemia: a heterogeneous disease that is not always iron refractory.

Donker AE, Schaap CC, Novotny VM, Smeets R, Peters TM, van den Heuvel BL, Raphael MF, Rijneveld AW, Appel IM, Vlot AJ, Versluijs AB, van Gelder M, Granzen B, Janssen MC, Rennings AJ, van de Veerdonk FL, Brons PP, Bakkeren DL, Nijziel MR, Vlasveld LT, Swinkels DW.

Am J Hematol. 2016 Dec;91(12):E482-E490. doi: 10.1002/ajh.24561.

46.

CBLB ubiquitin ligase: a major regulator of antifungal immunity.

van de Veerdonk FL, Netea MG.

Nat Med. 2016 Aug 4;22(8):834-5. doi: 10.1038/nm.4160. No abstract available.

PMID:
27490434
47.

Th2 and Th9 responses in patients with chronic mucocutaneous candidiasis and hyper-IgE syndrome.

Becker KL, Rösler B, Wang X, Lachmandas E, Kamsteeg M, Jacobs CW, Joosten LA, Netea MG, van de Veerdonk FL.

Clin Exp Allergy. 2016 Dec;46(12):1564-1574. doi: 10.1111/cea.12787. Epub 2016 Sep 18.

PMID:
27474157
48.

Aspergillus Cell Wall Chitin Induces Anti- and Proinflammatory Cytokines in Human PBMCs via the Fc-γ Receptor/Syk/PI3K Pathway.

Becker KL, Aimanianda V, Wang X, Gresnigt MS, Ammerdorffer A, Jacobs CW, Gazendam RP, Joosten LA, Netea MG, Latgé JP, van de Veerdonk FL.

MBio. 2016 May 31;7(3). pii: e01823-15. doi: 10.1128/mBio.01823-15.

49.

Reducing hypoxia and inflammation during invasive pulmonary aspergillosis by targeting the Interleukin-1 receptor.

Gresnigt MS, Rekiki A, Rasid O, Savers A, Jouvion G, Dannaoui E, Parlato M, Fitting C, Brock M, Cavaillon JM, van de Veerdonk FL, Ibrahim-Granet O.

Sci Rep. 2016 May 24;6:26490. doi: 10.1038/srep26490.

50.

LC3-associated phagocytosis: a crucial mechanism for antifungal host defence against Aspergillus fumigatus.

Sprenkeler EG, Gresnigt MS, van de Veerdonk FL.

Cell Microbiol. 2016 Sep;18(9):1208-16. doi: 10.1111/cmi.12616. Epub 2016 Jul 6. Review.

PMID:
27185357

Supplemental Content

Loading ...
Support Center